000 | 01887 a2200601 4500 | ||
---|---|---|---|
005 | 20250517110602.0 | ||
264 | 0 | _c20170810 | |
008 | 201708s 0 0 eng d | ||
022 | _a1540-9538 | ||
024 | 7 |
_a10.1084/jem.20160283 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVerstovsek, Srdan | |
245 | 0 | 0 |
_aRole of neoplastic monocyte-derived fibrocytes in primary myelofibrosis. _h[electronic resource] |
260 |
_bThe Journal of experimental medicine _c08 2016 |
||
300 |
_a1723-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBone Marrow _xpathology |
650 | 0 | 4 | _aBone Marrow Transplantation |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 | _aFibrosis |
650 | 0 | 4 |
_aHomeodomain Proteins _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 |
_aMonocytes _xcytology |
650 | 0 | 4 | _aNitriles |
650 | 0 | 4 |
_aPrimary Myelofibrosis _xetiology |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 | _aPyrimidines |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 |
_aSerum Amyloid P-Component _xpharmacology |
700 | 1 | _aManshouri, Taghi | |
700 | 1 | _aPilling, Darrell | |
700 | 1 | _aBueso-Ramos, Carlos E | |
700 | 1 | _aNewberry, Kate J | |
700 | 1 | _aPrijic, Sanja | |
700 | 1 | _aKnez, Liza | |
700 | 1 | _aBozinovic, Ksenija | |
700 | 1 | _aHarris, David M | |
700 | 1 | _aSpaeth, Erika L | |
700 | 1 | _aPost, Sean M | |
700 | 1 | _aMultani, Asha S | |
700 | 1 | _aRampal, Raajit K | |
700 | 1 | _aAhn, Jihae | |
700 | 1 | _aLevine, Ross L | |
700 | 1 | _aCreighton, Chad J | |
700 | 1 | _aKantarjian, Hagop M | |
700 | 1 | _aEstrov, Zeev | |
773 | 0 |
_tThe Journal of experimental medicine _gvol. 213 _gno. 9 _gp. 1723-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1084/jem.20160283 _zAvailable from publisher's website |
999 |
_c26287532 _d26287532 |